Juan Antonio Sanchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Juan Antonio Sanchez has a total of 368 co-authors. Here are the top co-authors by number of shared publications:
- Nilanjana Maulik
Molecular Cardiology and Angiogenesis Laboratory, Department of Surgery, University of Connecticut School of Medicine, Farmington, CT 06030, USA
14 shared publications Vaithinathan Selvaraju
Molecular Cardiology and Angiogenesis Laboratory University of Connecticut Health Farmington CT
14 shared publicationsMahesh Thirunavukkarasu
Molecular Cardiology and Angiogenesis Laboratory University of Connecticut Health Farmington CT
13 shared publicationsE A Rose
8 shared publicationsC R Smith
7 shared publicationsDavid W. McFadden
Department of Surgery University of Connecticut Health Farmington CT
6 shared publications
Latest Publications
- 31 March 2023
- Published by Elsevier
- p. 191-204
Surgical site and other acquired perioperative infections
- 31 March 2023
- Published by Elsevier
- p. 191-204
Surgical site and other acquired perioperative infections
- 31 March 2023
- Published by Elsevier
Contributors
- 1 June 2019
- Published by Elsevier in Current Problems in Surgery
- Vol. 56 (6) , 211-246
Performance improvement in surgery
- 1 June 2019
- Published by Elsevier in Current Problems in Surgery
- Vol. 56 (6) , 211-246
Performance improvement in surgery
- 1 June 2019
- Published by Elsevier in Current Problems in Surgery
- Vol. 56 (6) , 204-208
Performance improvement in surgery
- 1 June 2019
- Published by Elsevier in Current Problems in Surgery
- Vol. 56 (6) , 204-208
Performance improvement in surgery
- 28 November 2018
- Published by Bentham Science Publishers Ltd.
- p. 192-201
Subject Index
- 28 November 2018
- Published by Bentham Science Publishers Ltd.
List of Contributors
- 1 October 2018
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 227 (4) , e91-E91
Government-Based Insurance is Associated with Fewer Arterial Conduits in Coronary Artery Bypass Grafting
- 1 October 2018
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 227 (4) , e91-E91
Government-Based Insurance is Associated with Fewer Arterial Conduits in Coronary Artery Bypass Grafting
- 1 October 2018
- Published by Elsevier in Hepatobiliary & Pancreatic Diseases International
- Vol. 17 (5) , 430-436
Detecting accidental punctures and lacerations during cholecystectomy in large datasets: Two methods of analysis
- 1 October 2018
- Published by Elsevier in Hepatobiliary & Pancreatic Diseases International
- Vol. 17 (5) , 430-436
Detecting accidental punctures and lacerations during cholecystectomy in large datasets: Two methods of analysis
- Open Access
- 18 September 2018
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 7 (18) , e007601
Disruption of VEGF Mediated Flk‐1 Signaling Leads to a Gradual Loss of Vessel Health and Cardiac Function During Myocardial Infarction: Potential Therapy With Pellino‐1
Background: The present study demonstrates that the ubiquitin E3 ligase, Pellino‐1 (Peli1), is an important angiogenic molecule under the control of vascular endothelial growth factor (VEGF) receptor 2/Flk‐1. We have previously reported increased survivability of ischemic skin flap tissue by adenovirus carrying Peli1 (Ad‐Peli1) gene therapy in Flk‐1 +/− mice. Methods and Results: Two separate experimental groups of mice were subjected to myocardial infarction ( MI ) followed by the immediate intramyocardial injection of adenovirus carrying LacZ (Ad‐LacZ) (1×10 9 pfu) or Ad‐Peli1 (1×10 9 pfu). Heart tissues were collected for analyses. Compared with wild‐type ( WTMI ) mice, analysis revealed decreased expressions of Peli1, phosphorylated (p‐)Flk‐1, p‐Akt, p‐ eNOS , p‐ MK 2, p‐IκBα, and NF ‐κB and decreased vessel densities in Flk‐1 +/− mice subjected to MI (Flk‐1 +/− MI ). Mice ( CD 1) treated with Ad‐Peli1 after the induction of MI showed increased β‐catenin translocation to the nucleus, connexin 43 expression, and phosphorylation of Akt, eNOS , MK 2, and IκBα, that was followed by increased vessel densities compared with the Ad‐LacZ–treated group. Echocardiography conducted 30 days after surgery showed decreased function in the Flk1 +/− MI group compared with WTMI , which was restored by Ad‐Peli1 gene therapy. In addition, therapy with Ad‐Peli1 stimulated angiogenic and arteriogenic responses in both CD 1 and Flk‐1 +/− mice following MI . Ad‐Peli1 treatment attenuated cardiac fibrosis in Flk‐1 +/− MI mice. Similar positive results were observed in CD 1 mice subjected to MI after Ad‐Peli1 therapy. Conclusion: Our results show for the first time that Peli1 plays a unique role in salvaging impaired collateral blood vessel formation, diminishes fibrosis, and improves myocardial function, thereby offering clinical potential for therapies in humans to mend a damaged heart following MI .
- 18 September 2018
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 7 (18) , e007601
Open AccessDisruption of VEGF Mediated Flk‐1 Signaling Leads to a Gradual Loss of Vessel Health and Cardiac Function During Myocardial Infarction: Potential Therapy With Pellino‐1
Background: The present study demonstrates that the ubiquitin E3 ligase, Pellino‐1 (Peli1), is an important angiogenic molecule under the control of vascular endothelial growth factor (VEGF) receptor 2/Flk‐1. We have previously reported increased survivability of ischemic skin flap tissue by adenovirus carrying Peli1 (Ad‐Peli1) gene therapy in Flk‐1 +/− mice. Methods and Results: Two separate experimental groups of mice were subjected to myocardial infarction ( MI ) followed by the immediate intramyocardial injection of adenovirus carrying LacZ (Ad‐LacZ) (1×10 9 pfu) or Ad‐Peli1 (1×10 9 pfu). Heart tissues were collected for analyses. Compared with wild‐type ( WTMI ) mice, analysis revealed decreased expressions of Peli1, phosphorylated (p‐)Flk‐1, p‐Akt, p‐ eNOS , p‐ MK 2, p‐IκBα, and NF ‐κB and decreased vessel densities in Flk‐1 +/− mice subjected to MI (Flk‐1 +/− MI ). Mice ( CD 1) treated with Ad‐Peli1 after the induction of MI showed increased β‐catenin translocation to the nucleus, connexin 43 expression, and phosphorylation of Akt, eNOS , MK 2, and IκBα, that was followed by increased vessel densities compared with the Ad‐LacZ–treated group. Echocardiography conducted 30 days after surgery showed decreased function in the Flk1 +/− MI group compared with WTMI , which was restored by Ad‐Peli1 gene therapy. In addition, therapy with Ad‐Peli1 stimulated angiogenic and arteriogenic responses in both CD 1 and Flk‐1 +/− mice following MI . Ad‐Peli1 treatment attenuated cardiac fibrosis in Flk‐1 +/− MI mice. Similar positive results were observed in CD 1 mice subjected to MI after Ad‐Peli1 therapy. Conclusion: Our results show for the first time that Peli1 plays a unique role in salvaging impaired collateral blood vessel formation, diminishes fibrosis, and improves myocardial function, thereby offering clinical potential for therapies in humans to mend a damaged heart following MI .
- 1 April 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 105 (4) , 994-999
Decision Making, Evidence, and Practice
- 1 April 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 105 (4) , 994-999
Decision Making, Evidence, and Practice